Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-065069
Filing Date
2025-05-07
Accepted
2025-05-07 08:37:27
Documents
68
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q iron-20250331.htm   iXBRL 10-Q 2224140
2 EX-10.1 iron-ex10_1.htm EX-10.1 138474
3 EX-31.1 iron-ex31_1.htm EX-31.1 16729
4 EX-31.2 iron-ex31_2.htm EX-31.2 16419
5 EX-32.1 iron-ex32_1.htm EX-32.1 10006
  Complete submission text file 0000950170-25-065069.txt   8452467

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT iron-20250331.xsd EX-101.SCH 1410894
71 EXTRACTED XBRL INSTANCE DOCUMENT iron-20250331_htm.xml XML 1122627
Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39438 | Film No.: 25919459
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)